Michael Williams
University of Virginia School of Medicine

Last Updated On 2/1/2021 12:45:59 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
No Relationships to Disclose

Stock and Other Ownership Interests
No Relationships to Disclose

Honoraria
Company: Xian Janssen
Recipient: You

Consulting or Advisory Role
Company: Celgene
Recipient: You
Company: TG Therapeutics
Recipient: You
Company: Gilead Sciences
Recipient: You
Company: AstraZeneca
Recipient: You
Company: Kite Pharma
Recipient: You
Company: Ascentage Pharma Group
Recipient: You
Company: Abbvie
Recipient: You
Company: Janssen Oncology
Recipient: You
Company: Pharmacyclics
Recipient: You
Company: Kymera Therapeutics
Recipient: You

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: Celgene
Recipient: Your Institution
Company: Janssen
Recipient: Your Institution
Company: Pharmacyclics
Recipient: Your Institution
Company: Gilead Sciences
Recipient: Your Institution
Company: Allos Therapeutics
Recipient: Your Institution
Company: Takeda
Recipient: Your Institution
Company: TG Therapeutics
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
No Relationships to Disclose

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
Company: Celgene
Recipient: You
Company: Takeda
Recipient: You
Company: Xian-Janssen Pharmaceutical
Recipient: You
Company: Abbvie
Recipient: You
Company: TG Therapeutics
Recipient: You

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
No Relationships to Disclose

(OPTIONAL) Open Payments Link
not answered